CLINIQUE FRANÇAISE DES MALADIES DE LA PEAU
avec le soutien du Pr Wolkenstein, l Association de France-Hôpitaux Russes
+7(921)954-24-53     +7(812)272-62-03

() - [1].

, , , ( 1 ) 10-20% . 2-3% , [2].

, , .

:

, - .

() , , , - [3], [4]. , [5], [6]. , Toll like , , Th2 -, , , , - , - , , ... [7].

, , , , [8]. , . , , , ( ) [9].

:

1. STRACHAN DP. Family size, infection and atopy : the first decade of the "hygiene hypothesis". Thorax, 2000, 55 Suppl 1:S2-S10

2. XU F, YAN S, LI F et al. Prevalence of childhood atopic dermatitis : an urban and rural community-based study in Shanghai, China. PLoS One, 2012, 7(5):e36174.

3. PALMER CN, IRVINE AD, TERRON-KWIATKOWSKI A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature genetics, 2006, 38 : 441-446.

4. IRVINE AD, MCLEAN WH, LEUNG DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med, 2011, 365 : 1315-1327.

5. ISMAIL IH, OPPEDISANO F, JOSEPH SJ et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol, 2012, 23 : 674-681.

6. BATH-HEXTALL FJ, BIRNIE AJ, RAVENSCROFT JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema : an updated Cochrane review. Br J Dermatol, 2011, 164 : 228.

7. WILSON SR, THE L, BATIA LM et al. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch. Cell, 2013, 155 : 285-295.

8. LUCKY AW, LEACH AD, LASKARZEWSKI P, WENCK H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol, 1997, 14 : 321-324.

9. SCHMITT J, SCHMITT N, MEURER M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol, 2007, 21 : 606-619.

* - ,
.
.